ORAL INHIBITOR OF TISSUE TRANSGLUTAMINASE PREVENTS MUCOSAL DAMAGE IN CELIAC PATIENTS UNDERGOING GLUTEN CHALLENGE

Jorma Isola  1     Tina Friesing-Sosnik  2     Yurdagül Zopf  3     Mika Scheinin  4     valerie byrnes  5     Detlef Schuppan  5     Helga Török  6    
1 Tampere University, Tampere, Finland
2 University Medical Center, Research Center for Immune Therapy, Mainz, Germany
3 Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
4 Clinical Research Services Turku - CRST Oy, Turku, Finland
5 University College Hospital Galway, Galway, Ireland
6 University Hospital, LMU Munich, Munich, Germany

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing